乙型肝炎/人类免疫缺陷病毒共感染与乙型肝炎单感染患者的乙型肝炎病毒相关照护质量:一项全国队列研究
研究回顾性评估2019年美国退伍军人健康管理局系统中全部HBV-HIV共感染与HBV单感染患者对HBV相关照护指南的依从性。共感染者的指南依从率与单感染者相似或更高;无专科照护者接受抗病毒治疗和HCC监测的比例较低;同时接受消化科与感染科照护的共感染者HCC监测和HBV-DNA监测比例高于仅感染科照护者。
要点
- 共感染者HBV治疗率97%,单感染者71%;两组肝硬化患者半年一次HCC监测均为55%。
- 无专科照护者抗病毒治疗率39%,消化科80%,感染科84%;HCC监测率分别为16%、66%、47%。
- 共感染者同时接受消化科与感染科照护者HCC监测73%、HBV-DNA监测82%,均高于仅感染科照护者的31%和68%。
核心结论
- HBV-HIV共感染者接受指南依从性HBV相关照护的比例与HBV单感染者相似或更高。
- 同时接受消化科与感染科照护的HBV-HIV共感染者照护质量高于仅感染科照护者。
- 专科照护与HBV-HIV共感染者和HBV单感染者更高质量的HBV照护独立相关。
研究设计与样本
- 回顾性评估2019年美国退伍军人健康管理局全国医疗系统中所有HBV-HIV共感染与HBV单感染患者对HBV相关照护指南的依从性。
- 在8323名慢性HBV退伍军人中识别出1021例HBV-HIV共感染者。
主要发现
- HBV治疗率:HBV-HIV共感染97% vs HBV单感染71%。
- 肝硬化患者半年一次HCC监测率:HBV-HIV共感染55% vs HBV单感染55%。
- 甲型肝炎病毒筛查率:HBV-HIV共感染69% vs HBV单感染56%;丙型肝炎病毒筛查率:100% vs 99%;治疗中丙氨酸氨基转移酶监测率:95% vs 96%。
- 与消化科或感染科照护者相比,无专科照护者接受抗病毒治疗的比例较低(无专科39%;消化科80%;感染科84%),接受HCC监测的比例也较低(无专科16%;消化科66%;感染科47%);上述结果在多变量分析中持续存在。
- 与仅感染科照护相比,同时接受消化科与感染科照护的HBV-HIV共感染者接受HCC监测的比例更高(消化科+感染科73% vs 感染科31%),治疗中HBV-DNA监测比例也更高(消化科+感染科82% vs 感染科68%)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Guideline-adherent hepatitis B virus (HBV) care is critical for patients with HBV, particularly patients with HBV-human immunodeficiency virus (HIV) given increased risks of liver-related complications. However, a comprehensive assessment of HBV-related care in patients with HBV-HIV is lacking. METHODS: We retrospectively assessed adherence to HBV-related care guidelines in all patients with HBV-HIV and HBV monoinfection (HBV-M) in the national Veterans Health Administration healthcare system in 2019. RESULTS: We identified 1021 patients with HBV-HIV among 8323 veterans with chronic HBV. Adherence to HBV guidelines was similar or better in HBV-HIV versus HBV-M, including HBV treatment (97% vs 71%), biannual hepatocellular carcinoma (HCC) surveillance (55% vs 55%) for patients with cirrhosis, hepatitis A virus screening (69% vs 56%), hepatitis C virus screening (100% vs 99%), and on-therapy alanine aminotransferase monitoring (95% vs 96%). Compared with those seeing gastroenterology (GI) or infectious diseases (ID) providers, patients without specialty care were less likely to receive antiviral treatment (none, 39%; GI, 80%; ID, 84%) or HCC surveillance (none, 16%; GI, 66%; ID, 47%). These findings persisted in multivariable analysis. Compared with ID care alone, a higher proportion of patients with HBV-HIV seen dually by GI and ID received HCC surveillance (GI + ID 73% vs ID 31%) and on-therapy HBV-DNA monitoring (GI + ID, 82%; ID, 68%). CONCLUSIONS: Patients with HBV-HIV received similar or higher rates of guideline-adherent HBV-related care than patients with HBV-M. Patients with HBV-HIV under dual GI and ID care achieved higher quality care compared with ID care alone. Specialty care was independently associated with higher quality HBV care in patients with HBV-HIV and HBV-M.
引用
- Lee TH, Hunt CM, Maier MM, et al. Hepatitis B Virus-related Care Quality in Patients With Hepatitis B/Human Immunodeficiency Virus Coinfection Versus Hepatitis B Monoinfection: A National Cohort Study. Clin Infect Dis. 2022. PMID: 35349635. doi:10.1093/cid/ciac227
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。